Overview

Detailed Summary

Fineotex Chemical Limited is an Indian-origin specialty performance chemicals manufacturer and solutions provider producing tailor-made formulations across textiles, FMCG cleaning & hygiene, water treatment and oilfield chemicals, with manufacturing campuses in India, Malaysia and newly-additive U.S. facilities, focused on sustainable chemistries, technical services and export-led growth into developed markets.
The company materially strengthened its oilfield and water-treatment capability by acquiring a controlling stake in CrudeChem Technologies Group in December 2025, adding two U.S. plants, an advanced R&D lab, a ~80,000 MTPA manufacturing platform and established marquee clients, which the company expects to be EPS accretive and drive international revenue expansion.
Financial momentum showed strong top-line acceleration with Q3 FY26 consolidated revenue growing ~46% year‑on‑year to Rs.190 crore, coupled with an expanded international mix (48% exports in Q3 FY26), but gross and EBITDA margins compressed on consolidation, raw material mix changes and integration-related costs while the company remains essentially debt-free with strong cash reserves.
Sustainability and certifications are core differentiators: Fineotex highlights multiple accreditations including Bluesign, ZDHC, GOTS, FDA and GreenPro, plus EcoVadis and NABL recognition, and reports substantial R&D spend and water/energy intensity improvements, positioning the company to capture premium demand from eco-conscious buyers in EU/UK/US markets driven by recent trade deals.
Management has articulated a strategic playbook emphasizing inorganic growth, fungible global manufacturing capacity, cross-selling opportunities between textiles, cleaning and oilfield segments, and a medium-term ambition to scale to approximately $200 million revenue by 2030, driven by CrudeChem integration, export tailwinds and product innovation.

Sector: Chemicals
Industry: Chemicals - Speciality - Medium / Small
Market Cap: 2,626 Cr
Volatility: High Risk
P/E Ratio: 25.9
Industry P/E: 25.0
PEG Ratio: 1.5
P/B Ratio: 3.1
52W High: 35.76
52W Low: 19.21

Sales CAGR

1Y: -6.26%
3Y: 20.65%
5Y: 27.80%
10Y: 21.64%

Profit CAGR

1Y: -9.76%
3Y: 30.27%
5Y: 55.26%
10Y: 22.96%

ROE

TTM: 12.63%
3Y: 20.43%
5Y: 20.36%
10Y: 18.88%

ROCE

TTM: 16.75%
3Y: 26.63%
5Y: 26.66%
10Y: 25.69%

Technicals

‌

Forecasts

Unlock Premium Features

Analyst Target, Price, EPS and Revenue Projections

Peers

Symbol	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
FOSECOIND	5037.55	3,843 Cr	49.71	3.71	0.49	8.43	12.26	—
TATVA	1146.45	2,697 Cr	81.83	3.58	0.09	2.35	3.14	3.61
FCL	22.55	2,626 Cr	25.92	3.10	0.35	12.63	16.75	11.55
PLATIND	211.75	1,185 Cr	26.87	2.90	0.00	10.34	13.89	8.29
PAUSHAKLTD	415.05	1,024 Cr	28.11	2.13	0.60	9.47	10.40	5.87
JYOTIRES	813.85	977 Cr	14.28	4.13	1.11	29.00	38.69	18.24
SUNSHIEL	788.15	697 Cr	27.81	6.38	0.26	19.87	19.34	8.84

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

Ask AI

Consolidated Quarterly Results (in ₹ Crores)

View Standalone

Total Figures

QoQ Changes

Total Figures

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Sales	145	138	153	142	146	126	120	137	138	184
Expenses	107	98	115	107	109	92	99	112	107	149
Operating Profit	38	40	38	35	36	34	21	25	31	35
OPM %	26.31	29.14	25.02	24.84	24.97	27.23	17.77	18.38	22.53	18.96
Other Income	3.81	4.94	4.15	4.88	6.90	4.99	7.55	9.14	7.72	6.75
Interest	0.26	0.29	0.58	0.25	0.22	0.20	0.40	0.16	0.34	0.23
Depreciation	1.41	1.43	1.85	2.25	2.37	2.59	2.01	2.69	3.01	3.33
Profit Before Tax	40	44	40	38	41	36	26	31	35	38
Tax %	21.96	24.43	23.83	22.48	21.23	23.71	23.81	20.55	26.34	20.80
Net Profit	32	33	30	29	32	28	20	25	26	30
EPS in Rs	0.27	0.28	0.26	0.25	0.28	0.24	0.17	0.21	0.22	0.26

Consolidated Profit Loss (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	134	143	182	196	219	368	517	569	533	529
Expenses	98	111	148	162	178	297	404	421	406	411
Operating Profit	37	32	34	35	41	71	113	148	127	117
OPM %	27.42	22.24	18.89	17.72	18.57	19.34	21.78	26.08	23.85	22.17
Other Income	9.75	5.17	1.02	-11	17	5.52	7.30	17	24	29
Interest	0.39	0.57	0.83	0.63	0.72	0.92	0.82	1.33	1.07	0.98
Depreciation	0.63	0.65	1.00	1.17	1.47	2.51	4.28	6.02	9.22	9.66
Profit Before Tax	38	34	34	22	56	73	115	158	141	135
Tax %	23.93	29.35	27.65	34.84	20.24	22.38	21.99	23.19	22.68	22.23
Net Profit	29	24	24	14	45	57	90	121	109	105
EPS in Rs	0.24	0.20	0.20	0.11	0.37	0.47	0.76	1.03	0.93	0.87
Dividend Payout %	4.31	9.80	4.95	4.27	7.79	8.05	10.04	14.79	8.39	—

Consolidated Balance Sheet (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	22	22	22	22	22	22	22	22	22	23
Reserves	69	90	113	137	147	187	240	327	425	708
Borrowings	3.05	1.07	4.64	2.08	2.84	3.48	1.91	7.28	5.19	0.22
Other Liabilities	20	26	21	34	35	54	75	67	96	83
Total Liabilities	114	140	161	195	208	267	339	423	548	815
Fixed Assets	19	23	25	32	37	56	80	95	137	179
CWIP	0.00	0.00	0.12	0.14	0.63	4.60	0.00	0.36	0.00	21
Investments	39	51	59	52	56	36	21	93	151	330
Other Assets	56	66	77	110	114	171	238	234	260	284
Total Assets	114	140	161	195	208	267	339	423	548	815

Consolidated Cash Flows (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	14	19	6.34	12	28	9.20	13	107	97	69
Cash from Investing Activity	-13	-14	-5.72	5.00	-19	-7.25	0.67	-99	-47	-273
Cash from Financing Activity	-1.46	-5.85	-3.62	-3.44	-3.88	-4.44	-5.66	-6.44	-24	176
Net Cash Flow	-0.62	-0.87	-3.00	14	5.85	-2.49	8.39	1.36	26	-27

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Mar 2024	May 2024	Jun 2024	Jul 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Nov 2025	Dec 2025	Jan 2026
Promoters	65.03%	64.46%	64.46%	62.88%	62.88%	62.86%	62.88%	62.88%	62.88%	62.88%	62.57%	62.30%
FIIs	1.45%	0.97%	0.93%	3.14%	3.28%	3.36%	2.84%	2.51%	2.34%	2.16%	2.52%	2.94%
DIIs	3.70%	3.68%	3.68%	3.59%	3.63%	3.61%	3.71%	3.17%	1.63%	1.55%	1.28%	1.27%
Public	29.82%	30.89%	30.94%	30.39%	30.21%	30.17%	30.58%	31.44%	33.14%	33.40%	33.63%	33.48%
Total Shareholders	1,22,095	1,25,460	1,26,673	1,26,676	1,28,268	1,29,068	1,33,899	1,36,842	1,46,522	1,53,373	1,64,466	1,64,467

Market Transactions

Unlock Premium Features

Analyst Target, Price, EPS and Revenue Projections

Projection

Unlock Premium Features

Get In-depth insights on EPS and Revenue forecasts

Documents

Presentations

Concalls

Reports

Presentations

Investor Presentation

Q3 FY26

Investor Presentation

Q2 FY26

Investor Presentation

Q1 FY26

Available on Pro Plan